Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 10, 2005, Pages 1297-1303

  He, Ying ^a   Zeng, Su ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYCLOSPORIN; GLYCOPROTEIN P; GLYCOPROTEIN P INHIBITOR; MULTIDRUG RESISTANCE PROTEIN 2; RHODAMINE 123; RUTIN DECAHYDROSULFONATE SODIUM; RUTOSIDE DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL;

ARTICLE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG PROTEIN BINDING; DRUG TRANSPORT; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; INTESTINE EPITHELIUM; MONOLAYER CULTURE; PH; POLARIZATION; TEMPERATURE DEPENDENCE;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL MEMBRANE PERMEABILITY; CYCLOSPORINE; DRUG INTERACTIONS; FLAVONES; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, BIOLOGICAL; RHODAMINE 123; RUTIN; TEMPERATURE; VERAPAMIL;

EID: 27544500608     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.57.10.0008     Document Type: Article

References (31)

1. Balimane, P. V., Patel, K., Marino, A., Chong, S. (2004) Utility of 96 well Caco-2 cell system for increased throughput of P-gp screening in drug discovery. Eur. J. Pharm. Biopharm. 58: 99-105
2. Crowe, A. (2002) The influence of P-glycoprotein on morphine transport in Caco-2 cells. Comparison with paclitaxel. Eur. J. Pharmcol. 440: 7-16
3. Durr, D., Stieger, B., Kullak-Ublick, G. A., Rentsch, K. M., Steinert, H. C., Meier, P. J., Fattinger, K. (2000) St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin. Pharmacol. Ther. 68: 598-604
4. Eagling, V. A., Profit, L., Back, D. J. (1999) Inhibition of the CYP3A4-mediated metabolism and P-glycoprotein-mediated transport of the HIV-1 protease inhibitor saquinavir by grapefruit juice components. Br. J. Clin. Pharmacol. 48: 543-552
5. Ekins, S., Ring, B. J., Binkley, S. N., Hall, S. D., Wrighton, S. A. (1998) Autoactivation and activation of cytochrome P450s. Int. J. Clin. Pharmacol. Ther. 36: 642-651
6. Ekins, S., Kim, R. B., Leake, B. F., Dantzig, A. H., Schuetz, E. G., Lan, L. B., Yasuda, K., Shepard, R. L., Winter, M., Schuetz, J. D., Wikel, J. H., Wrighton, S. A. (2002) Application of three-dimensional quantitative structure-activity relationships of P-glycoprotein inhibitors and substrates. Mol. Pharmacol. 61: 974-981
7. El-Sayed, M., Rhodes, C. A., Ginski, M., Ghandehari, H. (2003) Transport mechanism(s) of poly (amidoamine) dendrimers across Caco-2 cell monolayers. Int. J. Pharm. 265: 151-157
8. Greenberger, L. M., Yang, C.-P. H., Gindin, E., Horwitz, S. B. (1990) Photoaffinity probes for the α1-adrenergic receptor and the calcium channel bind to a common domain in P-glycoprotein. J. Biol. Chem. 265: 4394-4401
9. Haritos, V. S., Ghabrial, H., Ahokas, J. T., Ching, M. S. (2000) Role of cytochrome P450 2D6 (CYP2D6) in the stereospecific metabolism of E- and Z-doxepin. Pharmacogenetics 10: 591-603
10. He, L., Liu, G. Q. (2002) Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. Acta Pharmacol. Sin. 23: 423-429
11. Hidalgo, I. J., Li, J. (1996) Carrier-mediated transport and efflux mechanisms in Caco-2 cells. Adv. Drug Deliv. Res. 22: 53-66
12. Hidalgo, I. J., Raub, T. J., Borchardt, R. T. (1989) Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96: 736-749
13. Houston, J. B., Kenworthy, K. E. (2000) In vitro-in vivo scaling of CYP kinetic data not consistent with the classical Michaelis-Menten model. Drug. Metab. Dispos. 28: 246-254
14. Hu, M., Chen, J. (2004) Nucleobase- and p-glycoprotein-mediated transport of AG337 in a Caco-2 culture Model. Mol. Pharmacol. 1: 194-200
15. Ioannides, C. (2002) Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32: 451-478
16. Korzekwa, K. R., Krishnamachary, N., Shou, M., Ogai, A. R. A. P., Rettie, A. E., Gonzalez, F. J. (1998) Evaluation of atypical cytochrome P450 kinetics with two-substrate-models: evidence that multiple substrates can simultaneously bind to cytochrome P450 active sites. Biochemistry 37: 4131-4147
17. Leonardi, M. G., Casartelli, M., Parenti, P., Giordana, B. (1998) Evidence for a low-affinity, high-capacity uniport for amino acids in Bombyx mori larval midgut. Am. J. Physiol. Regul. Integr. Comp. Physiol. 274: 1372-1375
18. Lu, L., Leonessa, F., Clarke, R., Wainer, I. W. (2001) Competitive and allosteric interactions in ligand binding to P-glycoprotein as observed on an immobilized P-glycoprotein liquid chromatographic stationary phase. Mol. Pharmacol. 59: 62-68
19. Maki, N., Hafkemeyer, P., Dey, S. (2003) Allosteric modulation of human P-glycoprotein. Inhibition of transport by preventing substrate translocation and dissociation. J. Biol. Chem. 278: 18132-18139
20. Mu, Q. Z., Shen, Y. M., Zhou, Q. L. (1998) China Patent ZL98116970
21. Nair, V. G., Bernstein, S. (1983) European Patent 0075626
22. Patel, J., Buddha, B., Dey, S., Pal, D., Mitra, A. K. (2004) In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am. J. Ther. 11: 262-277
23. A with P-glycoprotein in human intestinal epithelial cells. Eur. J. Pharmacol. 288: 187-192
24. Sandt, I., Blom-Roosemalen, M., Boer, A., Breimer, D. (2000) Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. Eur. J. Pharm. Sci. 11: 207-214
25. Sha, X., Fang, X. (2004) Transport characteristics of 9-nitro-camptothecin in the human intestinal cell line Caco-2 and everted gut sacs. Int. J. Pharm. 272: 161-171
26. Suzuki, H., Sugiyama, Y. (2000) Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 12: 3-12
27. Walgren, R. A., Walle, U. K., Walle, T. (1998) Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem. Pharmacol. 55: 1721-1727
28. Wang, X. J., Tang, Y. H., Yao, T. W., Zeng, S. (2004) Separation of rutin nona (H-) and deca (H-) sulfonate sodium by ion-pairing reversed-phase liquid chromatography. J. Chromatogr. A 1036: 229-232
29. Weierstall, T., Hollenberg, C. P., Boles, E. (1999) Cloning and characterization of three genes (SUT1-3) encoding glucose transporters of the yeast Pichia stipitis. Mol. Microbiol. 31: 871
30. Yamaguchi, H., Yano, I., Saito H., Inui, K. (2001) Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2. Eur. J. Pharmacol. 431: 297-303
31. Zhou, S., Lim, L. Y., Chowbay, B. (2004) Herbal modulation of P-glycoprotein. Drug Metab. Rev. 36: 57-104